Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Sleep Therapy Company Lofta Announces the Complete Path to Treating Sleep Apnea
  • USA - English


News provided by

Lofta, Inc

Aug 31, 2017, 22:50 ET

Share this article

Share toX

Share this article

Share toX


SAN DIEGO (PRWEB) August 31, 2017 -- Lofta, the San Diego-based sleep therapy company, announced today details of its newly developed Complete Path for sleep treatment and the lineup of available packages. The revolutionary Lofta concept grew out of Principal Jay Levitt’s own experience with treating sleep apnea—a process he found to be unusually frustrating. The novel healthcare company aims to eliminate these obstacles and streamline sleep treatment in an effort to benefit the millions of people nationwide who suffer from sleep apnea.

“The good news is that Lofta is changing all that,” says Levitt, “with a streamlined approach to treating sleep apnea that eliminates complexity and clears the path to better sleep—and better health."

Post this

“The existing paradigm is unnecessarily complicated, fragmented, and inefficient,” Levitt explained. “First individuals must determine if they have sleep apnea, and then they’ve got to deal with medical offices, overnights in sleep labs, and durable medical equipment suppliers—all with little or no information or support. It leads to a staggering failure rate.”

To combat this, Lofta has leveraged the technology and convenience of virtual care and home sleep testing to create its Complete Path—a holistic approach that allows clients to engage in a high-touch experience—from initial screening and sleep testing, through to diagnosis, therapy, and ongoing support. The entire diagnostic phase and commencement of treatment all takes place at home, typically under one week.

It’s estimated that one in five adults in the US have sleep apnea. Some people even get a diagnosis but forgo treatment because of the perceived stigma, or the belief that treating it is more trouble than it’s worth. And the truth is, the traditional experience is less than ideal. But it turns out that 75% of those with the most serious cases of sleep apnea are unaware they have it—a devastating statistic when you consider that an untreated sleep disorder has serious health consequences including increased risk for diabetes, heart disease, high blood pressure, and stroke.

“The good news is that Lofta is changing all that,” says Levitt, “with a streamlined approach to treating sleep apnea that eliminates complexity and clears the path to better sleep—and better health. People go their entire lives with undiagnosed and untreated sleep apnea. We know that the Lofta Complete Path can be a game changer in terms of improving daytime sleepiness, reducing complications from common sleep apnea co-morbidities and overall vitality.”

Clients participating in the Lofta subscription therapy packages receive not only the support of their own dedicated Lofta Sleep Coach, but emails with daily sleep data reports. As part of a growing trend where various wellness metrics can be tracked, this direct feedback engenders an increased personal investment in therapy. The company furthers the commitment to connected care by dispensing therapy devices that can be monitored and adjusted remotely for efficacy and comfort.

Lofta bypasses the maze of insurance reimbursement in favor of monthly and annual subscription plans, including 12-month, 0% APR financing available to qualified customers. The company aims to make treatment attainable and is so confident in its model that it offers a 45-night satisfaction guarantee with a full refund. The Complete Path for sleep apnea diagnosis, CPAP therapy devices, treatment, supplies, and the Lofta support plans—including RightStart45, Sleep365, and RX Express—can be accessed through lofta.com, launching in late 2017. 

Beyond implementing the Complete Path, Lofta is also launching a series of e-commerce microsites beginning with buyminicpap.com dedicated to the ResMed AirMini™, the world’s smallest and lightest travel CPAP machine. Easy-start bundles are available, as is information on screening, prescription services, and telemedicine consultations for those who suspect they may have sleep apnea.

About Lofta
Driven by a desire to streamline a needlessly complex experience, Lofta set out to elevate the treatment of sleep-disordered breathing. By removing the obstacles to relief that compound an already exhausting problem—the maze of insurance, arduous overnights at the sleep lab, and a too-common lack of guidance—Lofta clears the path to breathing easier by providing access to screening, tools, telemedicine, tests, supplies, and support all available in one place: home. Better sleep can change your life. And it’s never been easier. More information at lofta.com and buyminicpap.com.

Lofta Press Team
800-698-8000
sleep(at)lofta(dot)com

lofta.com | buyminicpap.com | Facebook | LinkedIn

1 Peppard et al. Am J Epidemiol 2013,
2 Young et al. Sleep 2008
3 Marshall et al. J Clin Sleep Med 2014

*Lofta is a Home Medical Device Retailer (HMDR) licensed in certain states to dispense durable medical equipment to facilitate the treatment of sleep-disordered breathing (SDB) as directed by a licensed physician. Lofta does not provide patient evaluations, diagnosis, care and/or treatment, and should never be relied upon as a substitute for, or resource in place of, a licensed medical practitioner. However, as a convenience to our clients and to facilitate the most streamlined path to treatment possible, Lofta may offer clients access to a virtual care platform** through which clients can establish an independent physician-patient relationship with a licensed physician (belonging to a third-party medical professional association***) of the client’s choosing. Lofta shall not be a party to such relationships. Alternatively, Lofta can take direction from a licensed physician with whom the client has already established a patient-physician relationship.
**Lofta Virtual Care is a telehealth platform Lofta has licensed and modified to facilitate improved communication between clients, independent physicians, and Lofta employees. This is a HIPAA compliant video conferencing tool with medical information. Lofta does not provide medical care through this tool, but independent licensed healthcare professionals and physician groups can license the use of this tool to provide diagnostic service to Lofta clients.
 
***Lofta Physicians, PA is a third-party medical professional association that has licensed the brand name of Lofta for use. Additionally, Lofta PA has licensed the use of the Lofta VC platform to interact with their patients. Lofta has no financial interest in Lofta PA and has no control over operational elements such as pricing decisions, physician selection, or licensing/compliance matters. Any relationship between a Lofta client and a physician working for Lofta PA is at the discretion of the client.

Jay B Levitt, Lofta, Inc, http://www.buyminicpap.com, +1 858-224-7000, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.